174 related articles for article (PubMed ID: 31591480)
1. MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway.
Yang W; Li Y; Gao R; Xiu Z; Sun T
Oncogene; 2020 Jan; 39(5):1098-1111. PubMed ID: 31591480
[TBL] [Abstract][Full Text] [Related]
2. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
3. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
Morrison BJ; Steel JC; Morris JC
BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
[TBL] [Abstract][Full Text] [Related]
4. IFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cells.
Shao S; Risch E; Burner D; Lu L; Minev B; Ma W
Int Immunopharmacol; 2017 Jun; 47():159-165. PubMed ID: 28410529
[TBL] [Abstract][Full Text] [Related]
5. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
Lorenzi S; Forloni M; Cifaldi L; Antonucci C; Citti A; Boldrini R; Pezzullo M; Castellano A; Russo V; van der Bruggen P; Giacomini P; Locatelli F; Fruci D
PLoS One; 2012; 7(10):e46928. PubMed ID: 23071666
[TBL] [Abstract][Full Text] [Related]
6. Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.
Brown CE; Starr R; Martinez C; Aguilar B; D'Apuzzo M; Todorov I; Shih CC; Badie B; Hudecek M; Riddell SR; Jensen MC
Cancer Res; 2009 Dec; 69(23):8886-93. PubMed ID: 19903840
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells.
Sun T; Li Y; Yang W; Wu H; Li X; Huang Y; Zhou Y; Du Z
J Cancer; 2019; 10(23):5638-5645. PubMed ID: 31737100
[No Abstract] [Full Text] [Related]
8. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.
Ueda R; Ohkusu-Tsukada K; Fusaki N; Soeda A; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2010 Feb; 126(4):919-29. PubMed ID: 19728337
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
Cilibrasi C; Riva G; Romano G; Cadamuro M; Bazzoni R; Butta V; Paoletta L; Dalprà L; Strazzabosco M; Lavitrano M; Giovannoni R; Bentivegna A
PLoS One; 2017; 12(1):e0169854. PubMed ID: 28081224
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors.
Seliger B
Cancer Immunol Immunother; 2008 Nov; 57(11):1719-26. PubMed ID: 18408926
[TBL] [Abstract][Full Text] [Related]
11. LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4.
Han S; Wang C; Qin X; Xia J; Wu A
J Exp Clin Cancer Res; 2017 Jun; 36(1):83. PubMed ID: 28641579
[TBL] [Abstract][Full Text] [Related]
12. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
13. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of exosomal MHC-I promotes glioma cells escaping from systemic immunosurveillance.
Sun T; Li Y; Wu J; Cao Y; Yang Y; He Y; Huang W; Liu B; Yang W
Nanomedicine; 2022 Nov; 46():102605. PubMed ID: 36113830
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
16. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
[TBL] [Abstract][Full Text] [Related]
17. Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
Cancer Immunol Immunother; 2022 Nov; 71(11):2691-2700. PubMed ID: 35364740
[TBL] [Abstract][Full Text] [Related]
18. [Glial tumor cell proliferation and immune response in the brain].
Yamasaki T; Akiyama Y; Fukuda M; Kimura Y; Moritake K; Enomoto K; Maeno T
Hum Cell; 1995 Sep; 8(3):99-106. PubMed ID: 8652453
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
